rosiglitazone has been researched along with Complication, Postoperative in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, M; Duan, X; Liu, K; Pan, Z; Qu, J; Zhang, F; Zhou, D; Zhou, Y | 1 |
| De Backer, O; Elinck, E; Lefebvre, RA; Leybaert, L; Priem, E | 1 |
| Alméras, N; Angel, J; Batalla, N; Bertrand, OF; Costerousse, O; De Larochellière, R; Després, JP; Dzavik, V; Natarajan, M; Poirier, P; Rinfret, S; Rodés-Cabau, J; Roy, L; Title, L | 1 |
| Aksakal, O; Gungor, T; Inan, I; Kalyoncu, S; Mollamahmutoglu, L; Sirvan, L; Sut, N; Yilmaz, B | 1 |
| Hyong, A; Jadhav, V; Lee, S; Rowe, J; Tang, J; Tong, W; Zhang, JH | 1 |
1 trial(s) available for rosiglitazone and Complication, Postoperative
| Article | Year |
|---|---|
A multicentre, randomized, double-blind placebo-controlled trial evaluating rosiglitazone for the prevention of atherosclerosis progression after coronary artery bypass graft surgery in patients with type 2 diabetes. Design and rationale of the VeIn-Coron
Topics: Adult; Aged; Angina Pectoris; Atherosclerosis; Blood Glucose; Coronary Artery Bypass; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypoglycemic Agents; Male; Middle Aged; Postoperative Complications; Prospective Studies; Quebec; Rosiglitazone; Spain; Thiazolidinediones; Treatment Outcome; Vasodilator Agents | 2009 |
4 other study(ies) available for rosiglitazone and Complication, Postoperative
| Article | Year |
|---|---|
Rosiglitazone Treatment Prevents Postoperative Fibrosis in a Rabbit Model of Glaucoma Filtration Surgery.
Topics: Actins; Animals; Autophagy; Blotting, Western; Conjunctiva; Connective Tissue Growth Factor; Disease Models, Animal; Fibroblasts; Fibrosis; Glaucoma; Hypoglycemic Agents; Intraocular Pressure; Male; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Polymerase Chain Reaction; Postoperative Complications; Rabbits; Real-Time Polymerase Chain Reaction; Rosiglitazone; Tenon Capsule; Trabeculectomy; Transforming Growth Factor beta1 | 2019 |
Peroxisome proliferator-activated receptor gamma activation alleviates postoperative ileus in mice by inhibition of Egr-1 expression and its downstream target genes.
Topics: Anilides; Animals; Blotting, Western; Colon; Cyclooxygenase 2; DNA; Down-Regulation; Early Growth Response Protein 1; Enzyme-Linked Immunosorbent Assay; Gastrointestinal Motility; Gene Expression; Heme Oxygenase-1; Ileus; Male; Mice; Mice, Inbred C57BL; Muscle, Smooth; Neutrophil Infiltration; Nitric Oxide Synthase Type II; Postoperative Complications; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2009 |
A randomised controlled trial on melatonin and rosiglitazone for prevention of adhesion formation in a rat uterine horn model.
Topics: Administration, Oral; Animals; Antioxidants; Disease Models, Animal; Female; Injections, Intraperitoneal; Melatonin; Postoperative Complications; Random Allocation; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones; Tissue Adhesions; Uterine Diseases; Uterus | 2010 |
Rosiglitazone, a PPAR gamma agonist, attenuates inflammation after surgical brain injury in rodents.
Topics: Analysis of Variance; Animals; Blood-Brain Barrier; Brain Edema; Brain Injuries; Disease Models, Animal; Drug Administration Schedule; Inflammation; Intraoperative Complications; Male; Neuroprotective Agents; Neurosurgical Procedures; Peroxidase; Postoperative Complications; PPAR gamma; Random Allocation; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones; Treatment Outcome | 2008 |